Euclid, OH, United States of America

Gregory B Foust

This inventor holds 1 USPTO granted patent. Top assignee: Abt Holding Company. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gregory B Foust. Retrieved from https://idiyas.com/inventor/gregory-b-foust-qlkearjl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gregory B. Foust: Innovator in Calcium-Sensing Receptor Technology

Introduction

Gregory B. Foust is a notable inventor based in Euclid, OH (US). He has made significant contributions to the field of biochemistry, particularly in the development of calcium-sensing receptors. His work has implications for understanding and treating various calcium receptor-mediated conditions.

Latest Patents

Foust holds a patent for the invention titled "Calcium-sensing receptor 2 (CaR2) and methods for using." This patent introduces a novel human calcium-sensing receptor named CaR2, along with the nucleotide sequence that encodes the receptor. The patent also includes antibodies specific for CaR2 and outlines methods for identifying modulators of the receptor. Furthermore, it describes how these identified modulators can be used to treat conditions related to calcium receptor activity.

Career Highlights

Gregory B. Foust is associated with Abt Holding Company, where he applies his expertise in receptor technology. His innovative work has positioned him as a key figure in the research and development of therapeutic solutions targeting calcium-related disorders.

Collaborations

Foust has collaborated with notable colleagues, including George Mbella Ekema and Pieter W. Faber. These partnerships have enhanced the scope and impact of his research endeavors.

Conclusion

Gregory B. Foust's contributions to the field of calcium-sensing receptors exemplify the importance of innovation in medical science. His patent for CaR2 represents a significant advancement in understanding calcium receptor functions and potential treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…